 Home > Active Ingredient News > Antitumor Therapy > Metz Medical and Boshengji Medical Technology reached a strategic cooperation to jointly promote the development of China's cell therapy technology

Metz Medical and Boshengji Medical Technology reached a strategic cooperation to jointly promote the development of China's cell therapy technology

 Last Update: 2021-09-18
 Source: Internet
 Author: User

Tags

research images

enterprise coral gables

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Picture: Dr.
Yang Lin (left), Chairman and CEO of Boshengji Pharmaceutical Technology, and Dr.
Fabao Zhang, Chairman of Metz Medical, signed the strategic cooperation agreement between the two parties

On September 15, 2021, the signing ceremony of the strategic cooperation between Boshengji Pharmaceutical Technology (Suzhou) Co.
, Ltd.
(hereinafter referred to as: Boshengji Pharmaceutical Technology) and Shanghai Meisi Pharmaceutical Technology Co.
, Ltd.
(hereinafter referred to as Meis Medicine) was held in Suzhou
.

Boshengji Medical Technology and Metz Medical have signed a strategic cooperation agreement between the two parties.

Dr.
Yang Lin, Chairman and CEO of Boshengji Pharmaceutical Technology, stated that Boshengji Pharmaceutical Technology is one of the first domestic companies engaged in the research and development of CAR-T and other immune cell therapy technologies and new drug development.
It has built six intelligent cell production line bases.

.

The Boshengji R&D team focuses on unmet clinical needs and has developed a variety of products covering hematological malignancies and solid tumors

, Boshengji Pharmaceutical Technology is one of the first domestic companies engaged in CAR-T and other immune cell therapy technology research and development and new drug development.

Dr.
Fabao Zhang, Chairman of Metz Medicine, said that Metz Medicine is a well-known professional clinical research platform in China, with strong academic strength and scientific research and academic service capabilities, and can provide important external resources and intellectual support
.

With rich project experience and platform tools such as clinical research design, database establishment, medical statistics, publishing plans, and results publicity, it provides overall solutions for clinical research and promotes clinical research sharing, collaborative transformation and promotion

Metz Medicine is a well-known professional clinical research platform in China.

--------

About Boshengji Pharmaceutical Technology :

Boshengji Pharmaceutical Technology (Suzhou) Co.
, Ltd.
was registered and established in Suzhou Industrial Park on May 31, 2010
.

Bo Shengji, PersonGen, the abbreviation of Personalized Gene Therapy, means dedicated to the research and development and innovation of personalized medicine technology.

Manage tumor immunodiagnosis and treatment

The company’s R&D center and laboratory are located in the Bio-Nano Park of Suzhou Industrial Park, equipped with complete cell therapy and molecular biology equipment, which can carry out the research and development of world-class new cell therapy technologies, covering the development of antigen binding domains and the optimization of CAR structure.
, CAR-T cell function test, up to the verification of in vivo efficacy test
.

It has an advanced CAR structure and function verification platform, CAR-T cell in vivo drug efficacy verification platform, Safeγ UCAR-γδ T cell drug development platform, iPSC-induced spot cell drug development platform, and NanoBa bispecific antibody development platform

About Metz Medicine :

MedSci is a comprehensive Internet platform for doctors.
It applies big data and artificial intelligence technology to link doctors, patients, and medical equipment companies, providing accurate digital medical communication solutions, optimizing medical ecology, improving medical quality, and creating better health.
Life
.

Precise

The main products of Metz Medical include digital medical communication and digital clinical research, covering clinical research, doctors' career growth, multi-channel academic communication, smart medical and other categories
.

At the level of digital clinical research, provide overall clinical research solutions, reduce costs and improve quality through digital technology; in terms of digital medical communication, provide digital professional medical content and accurate and integrated communication programs, and integrate the latest technology and knowledge.

Leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.